computational pathology
The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.
The company plans to use the funds to propel commercialization efforts and add new technology capabilities.
The new funds will be put towards growing its diagnostic and testing products.
Health Venture Partners led the round with participation from Breyer Capital, Kenan Turnacioglu and other funders.
The algorithm used by the Ibex Second Read system was developed using advanced machine learning techniques and trained on data sets from Maccabi's pathology institute.